SINTX Technologies (SINT) announces the transition of its Scientific Director


Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here.

SINTX Technologies, Inc. (NASDAQ: SINT), an original equipment manufacturer of advanced ceramics, today announced that its Scientific Director, Dr. Bryan J. McEntire, will retire at the end of 2021 after 17 years with the company. Dr Ryan Bock will serve as Vice President of Research and Development (R&D) to lead SINTX’s R&D activities. After his retirement, Dr McEntire will continue to support SINTX Technologies in the role of Chief Scientist Emeritus.

Dr McEntire has worked in the advanced ceramic industry for 46 years and has co-authored over 130 technical papers and presentations on ceramic materials, their processing and characterization. While at SINTX, he was responsible for research and development, product development, testing and validation, manufacturing and quality control of orthopedic implants made from silicon nitride. Prior to joining SINTX, McEntire held various executive positions at notable ceramics and materials companies including Applied Materials, Saint-Gobain Industrial Ceramics Corporation, Norton / TRW Ceramics and Ceramatec. He was elected a Fellow of the American Society in 2012 and was a guest speaker on ceramic training at the American Ceramic Society Annual Meeting from 1986 to 1995.

“Dr. McEntire has been a tremendous asset and a friend of SINTX for almost two decades,” said Dr. Sonny Bal, President and CEO of SINTX Technologies. “While we are sad to see him go, we are delighted that he continues to be involved through an advisory role. “

“It has been both a privilege and a pleasure to work with and for the great men and women of SINTX in the development of advanced ceramic solutions for the biomedical, industrial, aerospace and armor markets,” said Dr. Bryan J. McEntire. “I could not have ended my career with a more admirable organization, endowed with strong management leadership and exceptional technical and manufacturing talent. I wish them all the best in their future endeavors, and hope to be of assistance to them in my new role as advisor.

Currently Director of R&D, Dr Bock will continue his biomaterial development efforts in addition to expanding application-oriented research to antipathogenic and technical ceramic products as he assumes the role of Vice President of R&D when Dr McEntire will retire. Dr Bock has supported SINTX through a variety of roles for 13 years and has extensive experience in advanced ceramics, colloid and surface science, and biomaterials.

“I look forward to leading SINTX’s R&D efforts, which include rich collaborations with academic and industrial research groups around the world, as well as focused and application-oriented research carried out by our skilled and dedicated in-house team,” said Dr Ryan Bock, Director of R&D. , SINTX Technologies. “It has been my great honor to have Dr. McEntire as a mentor and colleague for many years of biomaterials development activities, including the discovery of new properties of silicon nitride that allow SINTX to deliver differentiated products in a ever increasing variety of market spaces. His expertise and advice will be greatly appreciated as we continue to find new applications for advanced ceramic materials. “


Comments are closed.